蓝丰生化
(002513)
| 流通市值：18.56亿 | | | 总市值：24.11亿 |
| 流通股本：2.89亿 | | | 总股本：3.76亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 652,131,097.94 | 2,342,107,165.64 | 1,829,738,679.83 | 1,196,198,328.15 |
| 营业收入 | 652,131,097.94 | 2,342,107,165.64 | 1,829,738,679.83 | 1,196,198,328.15 |
| 二、营业总成本 | 681,677,256.14 | 2,544,994,088.32 | 1,981,009,480.56 | 1,286,810,496.18 |
| 营业成本 | 612,193,620.34 | 2,268,760,983.95 | 1,785,534,296.38 | 1,163,164,890.77 |
| 税金及附加 | 4,206,809.05 | 17,800,167.32 | 12,424,274.64 | 8,184,165.49 |
| 销售费用 | 9,819,998.55 | 57,140,840.91 | 42,274,020.4 | 28,877,787.67 |
| 管理费用 | 35,276,536.09 | 90,557,639.09 | 53,729,745.31 | 33,141,412.46 |
| 研发费用 | 6,001,986.91 | 63,132,209.58 | 51,617,435.47 | 33,784,482.61 |
| 财务费用 | 14,178,305.2 | 47,602,247.47 | 35,429,708.36 | 19,657,757.18 |
| 其中:利息费用 | 13,364,557.56 | 53,542,140.24 | 36,040,313.63 | 22,752,873.07 |
| 其中:利息收入 | 2,576,584.11 | 6,846,819.64 | -3,433,453.01 | 2,118,503.09 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 6,623,621.82 | 2,381,382.19 | 4,609,993.25 | 4,177,928.22 |
| 资产处置收益 | 704,337.8 | -490,733.39 | -145,905.98 | -145,905.98 |
| 资产减值损失(新) | -10,650,431.19 | -80,941,989.04 | -13,440,142.77 | -10,183,033.49 |
| 信用减值损失(新) | -2,703,635.66 | -22,180,958.78 | 2,611,658.29 | 1,266,387.24 |
| 其他收益 | 3,878,636.26 | 20,007,035.87 | 19,391,828.99 | 15,060,249.48 |
| 四、营业利润 | -31,693,629.17 | -284,112,185.83 | -138,243,368.95 | -80,436,542.56 |
| 加:营业外收入 | 400,484.56 | 544,724.57 | 4,552,181.54 | 4,247,094.07 |
| 减:营业外支出 | 356,545.16 | 6,501,150.28 | 5,536,758.1 | 5,389,205.06 |
| 五、利润总额 | -31,649,689.77 | -290,068,611.54 | -139,227,945.51 | -81,578,653.55 |
| 减:所得税费用 | -4,011,015.33 | -18,286,770.15 | -23,057,408.1 | -17,436,502.95 |
| 六、净利润 | -27,638,674.44 | -271,781,841.39 | -116,170,537.41 | -64,142,150.6 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -27,638,674.44 | -271,781,841.39 | -116,170,537.41 | -64,142,150.6 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -14,841,689.9 | -190,525,337.53 | -77,182,058.48 | -44,778,940.38 |
| 少数股东损益 | -12,796,984.54 | -81,256,503.86 | -38,988,478.93 | -19,363,210.22 |
| 扣除非经常损益后的净利润 | -17,825,740.7 | -187,812,337.47 | -79,473,241.96 | -46,563,632.87 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.04 | -0.51 | -0.21 | -0.12 |
| (二)稀释每股收益 | -0.04 | -0.51 | -0.21 | -0.12 |
| 八、其他综合收益 | - | 891,217.38 | 1,111,437.39 | 1,111,437.39 |
| 归属于母公司股东的其他综合收益 | - | 944,888.44 | 1,111,437.39 | 1,111,437.39 |
| 九、综合收益总额 | -27,638,674.44 | -270,890,624.01 | -115,059,100.02 | -63,030,713.21 |
| 归属于母公司股东的综合收益总额 | -14,841,689.9 | -189,580,449.09 | -76,070,621.09 | -43,667,502.99 |
| 归属于少数股东的综合收益总额 | -12,796,984.54 | -81,310,174.92 | -38,988,478.93 | -19,363,210.22 |
| 公告日期 | 2026-04-30 | 2026-04-18 | 2025-10-25 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |